HIV/AIDS research initiative launched in South Africa

South Africa's Science and Technology Minister Naledi Pandor on Tuesday announced a government-sponsored research initiative that "aims to combat HIV and AIDS through scientific and technological research, the development of new drugs, diagnostic tests and vaccines," SAPA/IOL reports (7/28).

"[K]ey focus areas" of the South Africa HIV/AIDS Research and Innovation Platform (SHARP) will be prevention and therapeutics, according to BuaNews (7/28).

SHARP has received a $5.8 million pledge from the Department of Science and Technology over the next three years to fund nine research proposals, the AP/Google.com reports (7/28).

Pandor said SHARP will "give opportunities to young researchers who might not yet be established in the field, but who have bright ideas that deserve support," reports the Times. "Deputy Minister of Science and Technology, Derek Hanekom said that there was an 'opportunity to leverage finances and mobilise more funds' should the projects deliver on their objectives," according to the Times. The article includes information on some of the projects funded under the new initiative (McLea, 7/28).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine